搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
The Lancet
1 天
Acute lymphoblastic leukaemia relapse presenting as optic nerve infiltration
A 13-year-old male patient presented with a primary complaint of reduced vision in both eyes for the past 15 days at LV ...
7 小时
on MSN
Scottish schoolgirl among child cancer survivors who inspired poem about courage
Scottish schoolgirl among child cancer survivors who inspired poem about courage - Former children’s laureate Joseph Coelho ...
8 小时
on MSN
Brave Scots schoolgirl who survived leukaemia inspires incredible poem about courage
Fearne Stewart, from Blantyre, was diagnosed with acute lymphoblastic leukaemia - a cancer of the white blood cells - in ...
GEN
7 天
Gene Signature for High-Risk Form of Acute Lymphoblastic Leukemia Identified by CHOP Scientists
ALL, certain drugs work for some patients who relapse, but these drugs are not effective for all patients who relapse.
4 天
on MSN
Schoolgirls become best friends after meeting on cancer ward
Betsy, seven, and five-year-old Lacie have a very special friendship. Despite living less than a mile apart in Bridgend, and ...
News Medical on MSN
8 天
Gene Signature Identified for High-Risk Form Acute Lymphoblastic Leukemia
Researchers have discovered the underlying biology that identifies a subset of patients with acute lymphoblastic leukemia who ...
Cure Today
8 天
Focusing Research on T-Cell ALL to Further Treatment Options
An expert highlighted unmet needs in treating T-cell acute lymphoblastic leukemia and where research may focus in the future.
The American Journal of Managed Care
5 天
Advent of Ponatinib for Ph+ ALL Expected to Influence New Guidelines
With ponatinib (Iclusig) receiving an accelerated approval from the FDA earlier this year for the treatment of Philadelphia ...
Medpage Today on MSN
6 天
New CAR-T Drug Induces Durable Remissions in ALL, Published Data Show
Use of the anti-CD19 CAR T-cell therapy obecabtagene autoleucel (obe-cel; Aucatzyl) resulted in durable remissions among ...
2 天
Autolus Therapeutics Announces Publication of Data from the FELIX study of obe-cel in r/r ...
High overall response rate: 76.6% of patients in the pivotal cohort achieved CR/Cri following treatment with obe-cel with a median follow-up of ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈